MetaADEDB 2.0 @ LMMD
Cyclopentolate
(SKYSRIRYMSLOIN-UHFFFAOYSA-N)
Structure
SMILES
CN(CCOC(=O)C(C1(O)CCCC1)c1ccccc1)C
Type(s)
Approved
ATC code(s)
S01FA04; S01FA54
Molecular Formula:
C17H25NO3
Molecular Weight:
291.385
Log P:
2.1801
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
49.77
CAS Number(s):
512-15-2
Synonym(s)
1.
Cyclopentolate
2.
Cyclogyl
External Link(s)
MeSHD003519
PubChem Compound2905
BindingDB82375
ChEBI4024
CHEMBLCHEMBL1201338
DrugBankDB00979
DrugCentral757
IUPHAR/BPS Guide to PHARMACOLOGY7153
KEGGcpd:C06932
dr:D07759
Therapeutic Target DatabaseD0B1EV
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 612781295CTD
US FAERS
2MydriasisFAERS: 6
Canada Vigilance: 1		10750080CTD
Canada Vigilance
US FAERS
3DisorientationFAERS: 5SIDER
US FAERS
4AgitationFAERS: 3SIDER
US FAERS
5Anticholinergic SyndromeFAERS: 3OFFSIDES
US FAERS
6BradycardiaFAERS: 3OFFSIDES
US FAERS
7CyanosisFAERS: 3US FAERS
8ErythemaFAERS: 3
Canada Vigilance: 1		Canada Vigilance
US FAERS
9FlushingFAERS: 3SIDER
US FAERS
10NauseaFAERS: 312781295CTD
US FAERS
11OverdoseFAERS: 3US FAERS
12SomnolenceFAERS: 3SIDER
US FAERS
13SyncopeFAERS: 3US FAERS
14TremorFAERS: 3
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
15Visual ImpairmentFAERS: 3US FAERS
16VomitingFAERS: 3US FAERS
17Dry skinFAERS: 2US FAERS
18DysarthriaFAERS: 2US FAERS
19Eye painFAERS: 2US FAERS
20HeadacheFAERS: 2US FAERS
21IncoherentFAERS: 2SIDER
US FAERS
22Incorrect dose administeredFAERS: 2US FAERS
23RestlessnessFAERS: 2US FAERS
24Sudden onset of sleepFAERS: 2US FAERS
25Unresponsive to stimuliFAERS: 2US FAERS
26VertigoFAERS: 2SIDER
US FAERS
27Accidental exposureFAERS: 1US FAERS
28AnxietyFAERS: 1OFFSIDES
US FAERS
29Aortic bruitFAERS: 1US FAERS
30Benign Rolandic EpilepsyFAERS: 1US FAERS
31BlepharitisFAERS: 1US FAERS
32BlindnessFAERS: 1US FAERS
33Blood creatine phosphokinase MB increasedFAERS: 1US FAERS
34Blood glucose increasedFAERS: 1US FAERS
35Cerebral disorderFAERS: 1US FAERS
36Cerebrovascular accidentFAERS: 1US FAERS
37ChillsFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
38ClumsinessFAERS: 1US FAERS
39CryingFAERS: 1US FAERS
40DeliriumFAERS: 1US FAERS
41DiscomfortFAERS: 1US FAERS
42Drug dispensing errorFAERS: 1US FAERS
43Drug toxicityFAERS: 1OFFSIDES
US FAERS
44Eosinophil percentage increasedFAERS: 1US FAERS
45ErythropsiaFAERS: 1OFFSIDES
US FAERS
46Eye irritationFAERS: 1US FAERS
47Feeling abnormalFAERS: 1US FAERS
48HyperpyrexiaFAERS: 1SIDER
US FAERS
49Hypertensive crisisFAERS: 1US FAERS
50HypoventilationFAERS: 1US FAERS
51Inappropriate schedule of drug administrationFAERS: 1US FAERS
52Incorrect route of drug administrationFAERS: 1US FAERS
53InfluenzaFAERS: 1US FAERS
54Loss of personal independence in daily activitiesFAERS: 1US FAERS
55Lymphocyte percentage increasedFAERS: 1US FAERS
56Medication ErrorFAERS: 1US FAERS
57Mental status changesFAERS: 1US FAERS
58Muscle SpasticityFAERS: 1US FAERS
59MyoclonusFAERS: 1US FAERS
60Ocular discomfortFAERS: 1US FAERS
61PalpitationsFAERS: 1US FAERS
62Personality ChangeFAERS: 1OFFSIDES
US FAERS
63Prescribed overdoseFAERS: 1US FAERS
64PresyncopeFAERS: 1US FAERS
65PruritusFAERS: 1SIDER
US FAERS
66Respiratory distressFAERS: 1US FAERS
67Sinus TachycardiaFAERS: 1US FAERS
68StaringFAERS: 1US FAERS
69Supraventricular tachycardiaFAERS: 1US FAERS
70TachycardiaFAERS: 12113819CTD
SIDER
US FAERS
71Toxicity to various agentsFAERS: 1US FAERS
72Urinary RetentionFAERS: 1SIDER
US FAERS
73UrticariaFAERS: 1US FAERS
74Acid refluxOFFSIDES
75AgraphiaOFFSIDES
76Alopecia totalisOFFSIDES
77AlopeciaOFFSIDES
78AmnesiaOFFSIDES
79AnhedoniaOFFSIDES
80Ankle FractureOFFSIDES
81Anterior uveitisSIDER
82ApathyOFFSIDES
83ArthropathyOFFSIDES
84Ataxia19557378CTD
SIDER
85AtelectasisOFFSIDES
86AuraOFFSIDES
87Basal cell carcinomaOFFSIDES
88BlepharoconjunctivitisSIDER
89Blood GlucoseOFFSIDES
90Blood cholesterolOFFSIDES
91Blood count abnormalOFFSIDES
92Blood creatinine increasedOFFSIDES
93BruxismOFFSIDES
94CataractOFFSIDES
95CellulitisOFFSIDES
96Cerebral atrophyOFFSIDES
97ChoroiditisSIDER
98Chronic ulcerative colitisOFFSIDES
99Circumstance or information capable of leading to medication errorOFFSIDES
100CirrhosisOFFSIDES
101Color blindnessOFFSIDES
102ConfabulationOFFSIDES
103Confusion19557378CTD
104ConjunctivitisSIDER
105DemyelinationOFFSIDES
106Dental abscessOFFSIDES
107Depressed moodOFFSIDES
108DermatitisSIDER
109DrowsinessSIDER
110Drug ineffectiveCanada Vigilance: 2Canada Vigilance
111Drug ineffective for unapproved indicationCanada Vigilance: 1Canada Vigilance
112EpicondylitisOFFSIDES
113Eye InfectionOFFSIDES
114Eye RednessSIDER
115Fatigue12781295CTD
116Fever10750080CTD
117GastroenteritisSIDER
118GlaucomaOFFSIDES
119Hallucinations4816863
10750080		CTD
120HemiparesisOFFSIDES
121HyperkinesiaSIDER
122Intention tremorOFFSIDES
123Intervertebral Disc DegenerationOFFSIDES
124Intraocular inflammationOFFSIDES
125Iridocyclitis11004305CTD
OFFSIDES
SIDER
126Iris transillumination defectOFFSIDES
127IritisOFFSIDES
128LacrimationSIDER
129LeukoencephalopathyOFFSIDES
130Malignant neoplasm progressionOFFSIDES
131MetaplasiaOFFSIDES
132Musculoskeletal PainOFFSIDES
133Ocular ToxicityOFFSIDES
134OnychoclasisOFFSIDES
135Open reduction of fractureOFFSIDES
136Oral Cavity FistulaOFFSIDES
137OsteochondrosisOFFSIDES
138OsteomyelitisOFFSIDES
139OverweightOFFSIDES
140Pain11225579CTD
OFFSIDES
141PhotophobiaSIDER
142Physical disabilityOFFSIDES
143Portal HypertensionOFFSIDES
144Product quality issueOFFSIDES
145Product use in unapproved indicationCanada Vigilance: 1Canada Vigilance
146Psychomotor Agitation19557378CTD
147Psychoses, Substance-Induced

View details

491456
2761195
10750080
12781295
 		CTD
148Punctate keratitisSIDER
149Seizures2113819CTD
150SequestrectomyOFFSIDES
151Superinfection bacterialOFFSIDES
152Synovial CystOFFSIDES
153Therapeutic response unexpected with drug substitutionOFFSIDES
154Tooth ExtractionOFFSIDES
155Toxic anterior segment syndromeOFFSIDES
156Vasodilation procedureSIDER
157VasodilationSIDER
158Ventricular FibrillationOFFSIDES
159VerbigerationOFFSIDES
160Vision Disorders22247005CTD
161Vitamin K DeficiencyOFFSIDES
162Walking aid userOFFSIDES
163Wound dehiscenceOFFSIDES
164effusionOFFSIDES
165furuncleOFFSIDES
166pH body fluid abnormalOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.